Expression and characterization of recombinant canine IL-13 receptor α2 protein and its biological activity in vitro
- 31 January 2003
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 39 (12) , 719-727
- https://doi.org/10.1016/s0161-5890(02)00258-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Efficacy of soluble IL-4 receptor for the treatment of adults with asthmaJournal of Allergy and Clinical Immunology, 2001
- Reducing IgE levels as a strategy for the treatment of asthmaClinical and Experimental Allergy, 2000
- IL-13 in allergy: home at lastCurrent Opinion in Immunology, 1999
- Interleukin-4 Receptor in Moderate Atopic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Interleukin-4 and lnterleukin-13: Their Similarities and DiscrepanciesInternational Reviews of Immunology, 1998
- Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.American Journal of Respiratory and Critical Care Medicine, 1997
- Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor α ChainJournal of Biological Chemistry, 1996
- Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cellsInternational Immunology, 1995
- Activated mast cells produce interleukin 13.The Journal of Experimental Medicine, 1995